Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Chlorine Dioxide
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Undisclosed
Sponsor : Kitasato University
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : A study reported that ClO2 denatures the spike protein on the surface of SARS-CoV-2 and inhibits its binding to the human ACE2 receptor of SARS-CoV-2 (COVID-19 Virus), including its Alpha and Gamma variants.
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
November 06, 2021
Lead Product(s) : Chlorine Dioxide
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Sponsor : Kitasato University
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Chlorine Dioxide
Therapeutic Area : Gastroenterology
Study Phase : Phase IV
Sponsor : Stony Brook University
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
April 08, 2021
Lead Product(s) : Chlorine Dioxide
Therapeutic Area : Gastroenterology
Highest Development Status : Phase IV
Sponsor : Stony Brook University
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Chlorine Dioxide
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
An Outpatient Study Investigating Non-prescription Treatments for COVID-19
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
November 09, 2020
Lead Product(s) : Chlorine Dioxide
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable